What's new

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive

Feb 20, 2025 - 15:02
 0
Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive
Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, D...

Next Article

Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Posi...

Related Posts

Human medicines European public assessment report (EPAR): Kisunla, donanemab, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 March 2025, 09:00 (CET) to 28 March 2025, 14:00 (CET)

Twelfth Industry Standing Group (ISG) meeting, Online, ...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 4, 2025  0